Investors Sue Andrx Amid FDA Skirmish
Investors took legal action against drug maker Andrx Corp. Tuesday, accusing the pharmaceutical company of violating federal securities laws and misrepresenting the approval status of new drug applications with the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article